Laura Iris Ferro is a biotech entrepreneurs and innovators. She is the founder of Gentium S.p.A., a bio-pharmaceutical company specialized in the research, development and production of drugs for the treatment and prevention of diseases related to cancer and oncology treatments, the only Italian biotech company traded on the American stock exchange. She holds several executive positions as Vice President or Independent Director at pharmaceutical and medical products companies. Dr. Ferro is also the President of the Gianfranco Ferro Foundation, a not-for-profit Italian organization with the mission of stimulating research, education and dissemination of information on the correct use of medications and adverse effects of medicines. The Wall Street Journal defined her as one of the 10 European women to watch.